FDA Drug information
INVEGA SUSTENNA
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- INVEGA SUSTENNA PALIPERIDONE PALMITATE 117 mg/.75mL Janssen Pharmaceuticals, Inc.
- INVEGA SUSTENNA PALIPERIDONE PALMITATE 156 mg/mL Janssen Pharmaceuticals, Inc.
- INVEGA SUSTENNA PALIPERIDONE PALMITATE 234 mg/1.5mL Janssen Pharmaceuticals, Inc.
- INVEGA SUSTENNA PALIPERIDONE PALMITATE 39 mg/.25mL Janssen Pharmaceuticals, Inc.
- INVEGA SUSTENNA PALIPERIDONE PALMITATE 78 mg/.5mL Janssen Pharmaceuticals, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.